Targeting Lysine Demethylases in Cancer and Other Human Diseases / edited by Qin Yan
Material type:
E-bookSeries: (Advances in Experimental Medicine and Biology, 2214-8019 ; 1433).Publisher: Cham : Springer International Publishing , 2023Edition: 1st ed. 2023.Description: 1 recurso en línea.ISBN: 9783031381768.Subject: Aminoácidos
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | QP562 .L8 2023 EB (Browse shelf(Opens below)) | Acceso electrónico | ebook29022412 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| No cover image available | ||||||||
| QP562 .G5 G58 2014 EB Glutamate and ATP at the Interface of Metabolism and Signaling in the Brain | QP562 .G5 G58 2016 EB The Glutamate/GABA-Glutamine Cycle : Amino Acid Neurotransmitter Homeostasis | QP562.G55 G588 2015 EB Glutamine in Clinical Nutrition | QP562 .L8 2023 EB Targeting Lysine Demethylases in Cancer and Other Human Diseases | QP562.T7 ES International Journal of Tryptophan Research : IJTR | QP562.T7 T797 2015 EB Tryptophan Metabolism : Implications for Biological Processes, Health and Disease | QP563. D66 2015 EB Dopamine Receptor Technologies |
Chapter 1. Lysine demethylation in pathogenesis -- Chapter 2. Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases -- Chapter 3. KDM2 demethylases as drug targets -- Chapter 4. Role of histone demethylase KDM3 (JMJD1) in transcriptional regulation and cancer progression -- Chapter 5. KDM4 demethylases as drug targets -- Chapter 6. KDM5 lysine demethylases in pathogenesis, from basic science discovery to the clinic -- Chapter 7. Context-dependent functions of lysine demethylases in physiology and disease -- Chapter 8. KDM7 demethylases as drug targets.
This book provides a comprehensive summary of our current knowledge on lysine demethylases, a class of epigenetic regulators. It takes the reader on an exciting journey spanning the past two decades, starting from the initial discovery and characterization of these enzymes and leading up to the development of their small molecule modulators. These modulators have shown promise in clinical trials and hold great potential to improve patient outcomes. The book captures the progress made in this field and highlights the significant advancements that have paved the way for potential therapeutic applications. The book covers a wide range of topics, spanning both basic biology and clinical implications associated with lysine demethylases. It offers a comprehensive historical and conceptual framework for the discovery and characterization of similar epigenetic enzymes or modulators. Chapter one serves as an introductory overview, providing insights into the general characteristics and functions of lysine demethylases. In subsequent chapters, specifically chapters two to eight, each major family of lysine demethylases is individually explored in depth. By providing in-depth insights into the functional aspects of these enzymes, the book allows readers to grasp their significance in regulating cellular processes and influencing pathogenesis. Moreover, the book goes beyond fundamental knowledge and also explores the development of diagnostic and therapeutic strategies related to lysine demethylases. It highlights the potential for utilizing these enzymes as therapeutic targets for the treatment of various diseases, including cancer and infectious diseases. Additionally, the book highlights future directions aimed at further unraveling the roles of lysine demethylases and translating these findings into the clinic.
There are no comments on this title.